BRIEF published on 10/30/2025 at 21:05, 6 months 6 days ago TME Pharma's Semi-Annual Report and Financial Restructuring Financial Results Biotechnology CEO Appointment Bond Issuance TME Pharma
PRESS RELEASE published on 10/30/2025 at 21:00, 6 months 6 days ago TME Pharma publishes its semi annual results and half-year report TME Pharma publishes semi annual results and half-year report showing cost reductions, new CEO, and fundraising activities. Focus on NOX-A12 and NOX-E36 assets Fundraising Cost Reductions TME Pharma NOX-A12 Semi Annual Results
PRESS RELEASE published on 09/01/2025 at 08:45, 8 months 5 days ago Inside Information: Other news releases TME Pharma completes August financing, with €500k cash received on August 28th, bringing cash position to €2.35M. Organization aims to attract financing for cancer and eye therapies Cash Position TME Pharma August Financing Cost-efficient Organization Novel Therapies
BRIEF published on 09/01/2025 at 08:45, 8 months 5 days ago TME Pharma successfully completes its August fundraising round Biotechnology Fundraising Treasury Cryptocurrencies Cancer
BRIEF published on 08/25/2025 at 08:05, 8 months 12 days ago TME Pharma Secures €500,000 through New Bond Issue Investment Strategy Cost Reduction Bond Issuance Financial Strategy Shareholder Commitments
PRESS RELEASE published on 08/25/2025 at 08:00, 8 months 12 days ago Inside Information / Other news releases TME Pharma to raise €500k through bond issue & receives new shareholding notice. CEO & Chairman also invest. Funds to boost financial position & support R&D projects & investment strategy Fundraising Shareholding CEO Bond Issue TME Pharma
BRIEF published on 07/08/2025 at 08:05, 9 months 29 days ago TME Pharma Terminates Liquidity Contract Amid Cost Optimization Liquidity Contract Biotechnology Refinancing Cost Optimization TME Pharma
PRESS RELEASE published on 07/08/2025 at 08:00, 9 months 29 days ago Inside Information / Other news releases TME Pharma terminates liquidity contract with Invest Securities to optimize costs. Improve trading volume of shares and healthy liquidity deemed contract unnecessary. Finds success in refinancing and reducing operational costs Liquidity Contract Cost Optimization Trading Volume Organizational Restructuring TME Pharma
BRIEF published on 05/21/2025 at 08:05, 11 months 16 days ago TME Pharma Enhances Financial Outlook with €1.7M Bond Commitments Strategic Partnerships Bond Issuance Clinical Programs Financial Visibility Cost Structure
PRESS RELEASE published on 05/21/2025 at 08:00, 11 months 16 days ago Inside Information / Other news releases TME Pharma extends financial visibility to May 2026 by securing €1.7M financing through regular bonds with attached warrants. CEO and board show strong commitment to company's success Clinical Programs TME Pharma Financial Visibility Regular Bonds Private Warrants
Published on 05/06/2026 at 12:00, 51 minutes ago ROM Awarded Custom Tracking Contract in the Middle East
Published on 05/06/2026 at 12:00, 51 minutes ago Lobe Sciences Reports Second Quarter 2026 Results and Highlights Continued Operational Progress
Published on 05/06/2026 at 09:01, 3 hours 50 minutes ago Apex Widens and Extends Newly Discovered Zone with Significant NdPr Enrichment (>30%)
Published on 05/06/2026 at 02:17, 10 hours 34 minutes ago Troubadour Announces Share Consolidation and Effective Date
Published on 05/06/2026 at 12:21, 30 minutes ago Hello Paris achieves successful train path ordering for 2027 timetable with IVU.rail
Published on 05/06/2026 at 11:38, 1 hour 13 minutes ago Drägerwerk AG & Co. KGaA: No vote on items 7 and 8 of the agenda at the Annual Shareholders’ Meeting on May 8, 2026 - Cancellation of the separate meeting of preferred shareholders
Published on 05/06/2026 at 10:45, 2 hours 6 minutes ago Thailand Approves $29 Billion Investment Wave as Data Center Demand Surges
Published on 05/06/2026 at 10:00, 2 hours 51 minutes ago 2026 Pacific Ocean International Festival of Rock Balancing and Arts Holds Grand Opening at Qixingtan Scenic Area on May 1st
Published on 05/06/2026 at 10:00, 2 hours 51 minutes ago Mallia Therapeutics Announces Publication and Congress Presentation on Accelerated Wound Healing with sCD83
Published on 05/06/2026 at 10:09, 2 hours 42 minutes ago Guillemot Corporation : Information regarding the total number of voting rights and shares 30/04/2026
Published on 05/06/2026 at 08:42, 4 hours 9 minutes ago Disclosure of shares outstanding and voting rights - 06.05.2026
Published on 05/05/2026 at 19:00, 17 hours 51 minutes ago Combined General Meeting of Air Liquide Shareholders of May 5, 2026
Published on 05/05/2026 at 18:03, 18 hours 48 minutes ago Aéroports de Paris SA - Shares and voting rights as of 30 April 2026
